1160844-44-9

Basic information

• Product Name: C₃₈H₄₅N₅O₁₁
• Synonyms: C₃₈H₄₅N₅O₁₁
• CAS NO: 1160844-44-9
• Molecular Weight: 747.802
• Mol File: 1160844-44-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 963.8±65.0 °C(Predicted)
• Density: 1.266±0.06 g/cm3(Predicted)
• CAS DataBase Reference: C₃₈H₄₅N₅O₁₁(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₈H₄₅N₅O₁₁(1160844-44-9)
• EPA Substance Registry System: C₃₈H₄₅N₅O₁₁(1160844-44-9)

Safety Data

• Hazardous Substances Data: 1160844-44-9(Hazardous Substances Data)

Usage

General Description

The chemical with the formula C38H45N5O11 is known as ergotamine. It is a complex molecule that belongs to the family of ergot alkaloids, which are naturally occurring compounds derived from the fungus Claviceps purpurea. Ergotamine is commonly used in the treatment of migraines and cluster headaches. It works by constricting blood vessels in the brain to alleviate the symptoms of these conditions. Additionally, it has been reported to have vasoconstrictive and oxytocic effects, making it useful in the management of postpartum hemorrhage. Despite its therapeutic benefits, ergotamine has potential side effects and interactions with other drugs, so it should be used under the supervision of a healthcare professional.

Upstream product

• 1160844-42-7 Boc-Phe-Lys (alloc)-OH 
• 623-04-1 4-aminobenzenemethanol 
• 147529-99-5 N^Ε-allyloxycarbonyl-L-lysine hydrochloride 
• 3674-06-4 Boc-Phe-ONSu 
• 7535-56-0 N-t-butoxycarbonyl-L-phenylalanine 4-nitrophenyl ester 
• 6298-03-9 (2S)-2-amino-6-{[(prop-2-en-1-yloxy)carbonyl]amino}hexanoic acid 
• 1160844-43-8 C₃₁H₄₂N₄O₇ 
• 7693-46-1 4-Nitrophenyl chloroformate 

Downstream Products

• 1160844-45-0 Boc-Phe-Lys(alloc)-PABC-PTX 
• 1197351-79-3 C₂HF₃O₂*C₅₀H₅₄N₈O₁₁ 

Relevant articles and documents

Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study

The generation of rationally designed polymer therapeutics via the conjugation of low molecular weight anti-cancer drugs to water-soluble polymeric nanocarriers aims to improve the therapeutic index. Here, we focus on applying polymer therapeutics to targ

CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES

Conjugates of polymers or copolymers having attached thereto an anti-angiogenesis agent and a bisphosphonate bone targeting agent, and processes of preparing same, are disclosed. Pharmaceutical compositions containing these conjugates and uses thereof in

Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate

-